Evidence map›Paper›PMID 18436821›Full record

ArticleInvestigative ophthalmology & visual science2008

Release of membrane-associated mucins from ocular surface epithelia.

Timothy D Blalock, Sandra J Spurr-Michaud, Ann S Tisdale, Ilene K Gipson

Open access · greenAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Engineering CAR-T cells to remodel the mucin-rich cancer cell glycocalyx.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Mucins as a New Frontier in Pulmonary Fibrosis.Journal of clinical medicine · 2019
    Review
  19. Efficacy of Huaier granule in patients with breast cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Timothy D BlalockSchepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, MA 02114, USA.
Sandra J Spurr-Michaud
Ann S Tisdale
Ilene K Gipson
Harvard University · USMassachusetts Eye and Ear Infirmary · US

Funding

MUCINS OF THE OCULAR SURFACER01EY003306 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI GIPSON, ILENE K. · 1985 to 2015
$8.9M
Shedding of the Membrane-associated Mucin MUC16 at the Ocular SurfaceF32EY016937 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI BLALOCK, TIMOTHY D · 2005 to 2007
$151k
NEI NIH HHS F32 EY 016937NEI NIH HHS F32 EY016937NEI NIH HHS R01 EY003306NEI NIH HHS R01 EY 03306
6 · The paper itself

Abstract

purposeThree membrane-associated mucins (MAMs)--MUC1, MUC4, and MUC16--are expressed at the ocular surface epithelium. Soluble forms of MAMs are detected in human tears, but the mechanisms of their release from the apical cells are unknown. The purpose of this study was to identify physiologic agents that induce ocular surface MAM release.

methodsAn immortalized human corneal-limbal epithelial cell line (HCLE) expressing the same MAMs as native tissue was used. An antibody specific to the MUC16 cytoplasmic tail was developed to confirm that only the extracellular domain is released into the tear fluid or culture media. Effects of agents that have been shown to be present in tears or are implicated in the release or shedding of MAMs in other epithelia (neutrophil elastase, tumor necrosis factor [TNF]), TNF-alpha-converting enzyme, and matrix metalloproteinase-7 and -9) were assessed on HCLE cells. HCLE cell surface proteins were biotinylated to measure the efficiency of induced MAM release and surface restoration. Effects of induced release on surface barrier function were measured by rose bengal dye penetrance.

resultsMUC16 in tears and in HCLE-conditioned medium lacked the cytoplasmic tail. TNF induced the release of MUC1, MUC4, and MUC16 from the HCLE surface. Matrix metalloproteinase-7 and neutrophil elastase induced the release of MUC16 but not of MUC1 or MUC4. Neutrophil elastase removed 68% of MUC16, 78% of which was restored to the HCLE cell surface 24 hours after release. Neutrophil elastase-treated HCLE cells showed significantly reduced rose bengal dye exclusion.

conclusionsResults suggest that the extracellular domains of MUC1, MUC4, and MUC16 can be released from the ocular surface by agents in tears. Neutrophil elastase and TNF, present in higher amounts in the tears of patients with dry eye, may cause MAM release, allowing rose bengal staining.

Indexed as

ADAM17 ProteinADAM ProteinsAnimalsBiotinylationCA-125 AntigenCells, CulturedCulture MediaEpithelial CellsEpithelium, CornealFemaleHumansLeukocyte ElastaseLimbus CorneaeMaleMatrix Metalloproteinase 7Matrix Metalloproteinase 9ADAM17 ProteinADAM ProteinsCA-125 AntigenCulture MediaLeukocyte ElastaseMatrix Metalloproteinase 7Matrix Metalloproteinase 9Membrane ProteinsMUC16 protein, humanMUC1 protein, humanMUC4 protein, humanMucin-1Mucin-4MucinsRose BengalTumor Necrosis Factor-alpha

Identifiers

PMID18436821
PMCPMC2622730
OpenAlexW2070952303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.